Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neurogen reports results from phase II trials of aplindore in RLS and PD

Oct. 15, 2008

Acura and King present top-line results for Acurox in abuse liability

Oct. 15, 2008

FDA agrees with Neurobiological to consolidate Viprinex phase III trials

Oct. 14, 2008

New treatment options for AD and other cognition disorders described in recent Roche patent

Oct. 14, 2008

Archimedes reports positive results from phase III study of NasalFent in cancer pain

Oct. 13, 2008

ReGen launches Colostrinin under the name Cognase in Cyprus

Oct. 13, 2008

FDA approves AstraZeneca's Seroquel XR for bipolar depression and mania

Oct. 13, 2008

New agents for neuropsychiatric disorders reported in recent patents

Oct. 13, 2008

Santhera launches Catena in Canada for Friedreich's ataxia

Oct. 10, 2008

Marinus presents update on phase II clinical trials of ganaxolone in epilepsy

Oct. 10, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...